Sarah joined Grund IP Group in 2020 as a European Patent Consultant, and has recently completed her qualifications as a German Patent Attorney (Patentanwaltin) and as a European Trademark and Design Attorney. She continues to perfect her skills in the drafting and prosecution of European, German and international (PCT) patent, trademark and design applications, in addition to preparing documents for both opposition proceedings and appeal hearings before the European Patent Office. Her technical expertise relates to inventions originating from the technical areas of oncology, genetics, immunology, virology, microbiology, molecular biology, biochemical techniques and diagnostics, pharmaceutical sciences and related medical devices in the mechanical arts.

Prior to pursuing a career in intellectual property law, Sarah studied genetics at the Paris Lodron University in Salzburg, Austria, and also molecular medicine at the University of Ulm, Germany. Her undergraduate studies focused on human and plant genetics, immunology, and stem cell research.

During the time of her master thesis, she worked in Prof. Dr. Karl Lenhard Rudolph’s group at the University of Ulm in addition to the Max-Planck-Research-Group of Stem Cell Aging. Her PhD thesis involved continued work in the field of onco-immunology, in particular on the signaling pathway of the pattern recognition receptor RIG-I, and the genetic modification of this pathway using CRISPR/Cas9 gene editing. Another important aspect of her work concerned the isolation and analysis of extracellular vesicles/exosomes from tumor cells, conducted with Prof. Dr. Hendrik Poeck’s group at the Department of Hematology and Oncology at the Klinikum Rechts der Isar, Munich, Germany.